Rvnc investors have opportunity to lead revance therapeutics, inc. securities fraud lawsuit with the schall law firm

Los angeles , jan. 20, 2025 /prnewswire/ -- the schall law firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against revance therapeutics, inc. ("revance" or "the company") (nasdaq: rvnc) for violations of §§10(b) and 20(a) of the securities exchange act of 1934 and rule 10b-5 promulgated thereunder by the u.s. securities and exchange commission. investors who purchased the company's securities between february 29, 2024 and december 6, 2024, inclusive (the "class period"), are encouraged to contact the firm before march 4, 2025.
RVNC Ratings Summary
RVNC Quant Ranking